News

HIV prevention pills are no different. The good news is PrEP (pre-exposure prophylaxis) is extremely effective and generally ...
HIV pre-exposure prophylaxis (PrEP) coverage by geography and population among PEPFAR countries, 2022–2023. Presented at: AIDS 2024; July 22-26, 2024; Munich, Germany. Poster EPC065.
Heterosexual people with HIV-positive partners: PrEP provides protection for HIV-negative partners in serodiscordant relationships. People who inject drugs : Sharing needles increases the risk of ...
Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...
Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...
Participants reported that believing that they were at risk for HIV and that PrEP prevents HIV were facilitating ... Poster presented at: ANAC2022; November 17-19, 2022; Tampa, FL. Want to read ...
A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect ...
For decades, HIV prevention relied on daily pills, but science has made incredible strides. The drug Lenacapavir, originally used for HIV treatment, has been shown to work as PrEP.
TAMPA, Fla. — Pre-exposure prophylaxis, or PrEP, is a daily pill or injection that can reduce the risk of contracting HIV. It's for people who don't have HIV, but are sexually active or at a ...
PrEPVacc was one of the first large, African-led HIV vaccine trials and one of the first trials to incorporate PrEP. Now it's shutting down, and no other vaccine trials are in late stages.
Insurance companies have to pay for PrEP under federal rules, but some skirt the requirement for free access to the treatment critical to preventing HIV.